Clinical Trial Update: Neoadjuvant Dose Dense MVAC in MIBC and Locally Advanced Urothelial Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 study update on neoadjuvant dose-dense MVAC therapy for muscle-invasive bladder cancer and locally advanced urothelial carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Muscle-invasive Bladder Cancer
• Urothelial Carcinoma

Snippet

Sponsor: Pusan National University Yangsan Hospital | Conditions: Muscle Invasive Bladder Cancer, Urothelial Carcinoma | Phase 2 | Status: UNKNOWN